Planning

Naloxone & Alternative Opioid Antagonists - Buffer Stock Storage & Management

  • Department of Health and Social Care

F01: Prior information notice (prior information only)

Notice identifier: 2024/S 000-010777

Procurement identifier (OCID): ocds-h6vhtk-044f4e

Published 3 April 2024, 2:21pm



Section one: Contracting authority

one.1) Name and addresses

Department of Health and Social Care

39 Victoria Street

London

SW1H 0EU

Contact

Darrell Griffith

Email

ccsinbox@dhsc.gov.uk

Country

United Kingdom

Region code

UKI32 - Westminster

Internet address(es)

Main address

https://www.gov.uk/government/organisations/department-of-health-and-social-care

Buyer's address

https://www.gov.uk/government/organisations/department-of-health-and-social-care

one.3) Communication

Additional information can be obtained from the above-mentioned address

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at

https://health-family.force.com/s/Welcome

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Naloxone & Alternative Opioid Antagonists - Buffer Stock Storage & Management

Reference number

C260521

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Market engagement exercise to assess the current and future capacity of the UK market to provide naloxone and potential alternative opioid antagonists.

two.1.5) Estimated total value

Value excluding VAT: £500,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33670000 - Medicinal products for the respiratory system

two.2.3) Place of performance

NUTS codes
  • UKI32 - Westminster

two.2.4) Description of the procurement

DHSC is conducting a market engagement exercise to understand more about the companies and services in the UK that can, or that are seeking to produce, distribute, supply and store different formulations of naloxone and of other drugs that can reverse the effect of an opioid overdose or of drugs taken with opioids.
The outcome of the market engagement will inform decisions around potential future procurement and storage of buffer stock as well as providing information on how the market could meet a potential increase in demand across the UK.

two.2.14) Additional information

For avoidance of doubt this is not a call for competition, the purpose is to seek feedback from the market that may inform the final specification and/or procurement approach to the goods and services.
It is essential to understand that this market engagement process is separate from the formal procurement process. When the formal procurement process begins through the publication of a contract notice, any supplier interested in the contractual opportunity must submit a tender, and all supplier bids will be evaluated on an equal basis and in accordance with the set criteria.

The market engagement brief and associated questionnaire can be found here: https://www.contractsfinder.service.gov.uk/Notice/b702d08b-f9d2-4f4b-8324-726e540e6177

two.3) Estimated date of publication of contract notice

1 July 2024


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes